Navigation Links
Bill & Melinda Gates Foundation Grants $5 Million For Infectious Disease Research At The Hebrew University Of Jerusalem

NEW YORK, Dec. 17 /PRNewswire/ -- The Hebrew University of Jerusalem Kuvin Center for the Study of Infectious and Tropical Diseases has received a $5 million grant from the Bill & Melinda Gates Foundation for research into visceral leishmaniasis. The project will be led by Professor Alon Warburg, a vector biologist at the Hebrew University's Faculty of Medicine, and will include experts from Hebrew University's Robert H. Smith Faculty of Agriculture, Food, and Environment.

The announcement of the grant comes one year after Bill Gates, founder and chairman of Microsoft Corp. and co-chair of the Bill & Melinda Gates Foundation, was honored by American Friends of The Hebrew University (AFHU) and The Hebrew University with the inaugural Einstein Award at a December 2 gala in New York. Speaking about the role of philanthropy in improving the human condition that evening, Mr. Gates remarked that in addition to government and business, "The final piece of the puzzle is research institutions like Hebrew University. They do the pure research that leads to innovations that, in turn, make a huge difference in people's lives."

The prestigious Einstein Award was inspired by the legacy of Albert Einstein, a founding father of The Hebrew University, who revolutionized human understanding and whose actions were rooted in the belief that true progress requires the alleviation of human suffering.

"The close alignment of the Bill & Melinda Gates Foundation' s and Hebrew University's focus on improving the lives of people in 'at risk' geographies was important to our decision to honor Bill Gates with the first Einstein Award," said Martin E. Karlinsky, president of American Friends of The Hebrew University and a prominent New York attorney. "We are honored and thrilled that they have chosen to partner with us to fight this terrible disease."

The project, entitled "Studies on the ecology and transmission dynamics of visceral leishmaniasis in Ethiopia," will seek to determine the drivers of transmission of the disease, which is also known as Kala-Azar. Sand flies contract the disease by ingesting the blood of an infected host and transmit it during subsequent blood meals. By studying the larval breeding habits of the sand flies and the genotypes and drug sensitivities of the leishmania parasites, the project aims to devise effective methods to control the disease.

An estimated 500,000 cases occur annually. The worst affected region in Africa is southern Sudan and northwest Ethiopia. Treatment of the disease involves a 30-day injection cycle but is frequently hindered by a high correlation of patients who are also infected with HIV/AIDS. Left untreated, leishmaniasis has a 95 percent fatality rate.

In addition to the experts from Hebrew University's Faculty of Medicine and Robert H. Smith Faculty of Agriculture, Food, and Environment, Prof. Warburg will be coordinating the collaboration of researchers from Addis Ababa University, Charles University in Prague, the Volcani Center and the Gertner Institute for Trauma and Emergency Medicine Research.

For more information and to support this and other projects at The Hebrew University working to alleviate the suffering of our world's most unfortunate, please visit or call AFHU at 212.607.8500.

About The Hebrew University of Jerusalem

The Hebrew University of Jerusalem, located on three campuses in Jerusalem and a fourth in Rehovot, is among the top 100 academic and research institutions worldwide. Approximately 23,000 students from over 70 countries choose Hebrew University for its seven academic Faculties in the Humanities, Law, Sciences, Social Sciences, Agriculture, Medicine, Dental Medicine and to take advantage of extensive opportunities to participate in groundbreaking research. Faculty and alumni of The Hebrew University have won seven Nobel Prizes within the past seven years.

About the American Friends of The Hebrew University

American Friends of The Hebrew University (AFHU) is a national, not-for-profit organization. AFHU conducts fundraising activities in support of The Hebrew University's internationally recognized community of leading scholars and scientists. AFHU helps to ensure Israel's well-being by nurturing the nation's greatest asset: the intellectual strength of its people.

    MEDIA CONTACT:                            AFHU CONTACT:
    David Kaiyalethe                          Joyce Grossman
    Dukas Public Relations                    AFHU National Office               
    212-704-7385                              212-607-8540

SOURCE American Friends of The Hebrew University

SOURCE American Friends of The Hebrew University
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Get Your Fruits & Veggies: CDC
2. Mount Sinai & ENT and Allergy Associates, LLP affiliate to fight cancer
3. Story ideas from molecular & cellular proteomics
4. Job picture for 2006 chemistry grads reasonably good, C&EN reports
5. Debut issue of Foot & Ankle Specialist
6. Congressional R&D Caucus co-chairs join scientists, engineers and graduate students
7. IU Health & Wellness: Research and insights from Indiana University
8. Genetic Engineering & Biotechnology News reports on clinical trials in developing countries
9. European Society of Human Reproduction & Embryology 24th annual meeting
10. IU Health & Wellness: New research findings from the Kinsey Institute
11. Riley Hospital for Children & Capital Institute of Pediatrics become international sister hospitals
Post Your Comments:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can ... Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey ... cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... As a ... Magna Cum Laude and his M.D from the David Geffen School of Medicine at ... returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
(Date:6/24/2016)... ... 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ... raise to $12 an hour by 2020 and then adjusting it yearly to increase at ... the minimum wage, assure the wage floor does not erode again, and make future increases ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology: